Search results
Sanofi forecasts moderate profit growth on Dupixent demand
Reuters via Yahoo News· 1 year ago(Reuters) -Sanofi forecast moderate earnings growth that undershot expectations, saying demand for...
Sanofi's Biggest Drug Shined. But The Rest Of Its Business Didn't.
Investor's Business Daily· 3 months agoSanofi stock undercut its 50-day line Thursday despite Dupixent outperformance as its earnings...
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – March 27, 2023 – Zacks.com announces the list of stocks featured...
Stock-Split Watch: Could These 2 Market-Beaters Be Next?
Motley Fool via Yahoo Finance· 3 months agoFor moves that don't improve the underlying strength of a company's business, stock splits garner a...
2 Smart Growth Stocks to Buy Hand Over Fist in 2024
Motley Fool via Yahoo Finance· 3 months agoThe stock market has given investors plenty to talk about over the last few years, and those who have stayed in it through the ups and downs have dealt...
Dow Jones, Financial Stocks Climb Off Lows Despite Economic Jitters; Baidu, ELF Beauty Show Strength
Investor's Business Daily· 1 year agoAfter two straight bearish reversals off highs, sellers knocked the Dow Jones Industrial Average and...
2 Top Healthcare Stocks Defying the Bear Market
Motley Fool· 1 year agoAmong them are HCA Healthcare (NYSE: HCA) and Regeneron (NASDAQ: REGN). With recession fears alive and well, HCA Healthcare might be an excellent stock...
This Stock Just Dropped By 15%: Is It a Buy?
Motley Fool· 6 months agoThis is when corporations often take the opportunity to announce business developments which could change their prospects -- and that's exactly what...
Healthcare Heroes: 3 Biotech Stocks Poised to Cure What Ails the Market
InvestorPlace via Yahoo Finance· 3 months agoBiotech stocks, and the sector in general, saw a widespread beat down over the past two years....
Sanofi CEO under pressure to woo investors after spending shock
Reuters via Yahoo News· 5 months ago(Reuters) -Sanofi's CEO is under pressure to tell investors how much more he will spend on research...
